Cite
MLA Citation
Georgina V Long et al.. “Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study.” Lancet oncology, vol. 20, no. 8, 2019, pp. 1083–1097. http://access.bl.uk/ark:/81055/vdc_100088831147.0x00000f